Abstract Introduction: The association between reduced physical activity and social isolation has been described in the literature, but the relationship between the level of adherence to protective measures among older adults during the COVID-19 pandemic and the effects of physical inactivity on frailty remains a significant knowledge gap. Objective: To analyze the effects of social distancing and isolation caused by the COVID-19 pandemic on frailty in the elderly and on their physical activities in primary health care in a basic health unit in Brazil. Materials and methods: A prospective cohort study conducted in households and basic health units. In the first wave, before the pandemic, the sample consisted of non-frail elderly (n = 168). After a mean follow-up of 762 days, a second wave was conducted in which the elderly were classified according to their level of exposure to social distancing and isolation (n = 100) and the outcomes “level of physical activity” and “frailty status” were observed. Sociodemographic and clinical questionnaires, the Mini-Mental State Examination, physical markers of frailty, and level of exposure to social distancing and isolation were used. Descriptive statistics, association, survival curves, and proportional hazards regression were used. Results: Of the elderly, 53% transitioned to pre-frailty and 21% showed a decrease in physical activity. There was a high percentage of low adherence to social distancing and isolation, and there was no association with physical activity and frailty (p = 0.288; p = 0.351, respectively). Women had a higher risk of being classified as prefrail or frail (2.53; 95% CI, 1.01-6.34) and of having a decrease in physical activity (2.13; 95% CI, 1.06-4.26). Conclusion: There was no association between protective measures of social distancing and isolation, physical activity, and frailty. Older people with reduced levels of physical activity should be encouraged to exercise to remain active and avoid the transition to frailty, functional decline, and dependency.

Resumen Introducción: la asociación entre la disminución de la actividad física y el aislamiento social ya ha sido descrita en la literatura, sin embargo la relación entre el nivel de adherencia de los ancianos a las medidas de protección durante la pandemia de covid-19 y los efectos causados por la inactividad física sobre la condición de fragilidad permanece con un importante vacío de conocimiento. Objetivo: analizar los efectos del distanciamiento y el aislamiento social generados por la pandemia de covid-19 sobre la fragilidad de los ancianos y las actividades físicas realizadas por ellos en la atención primaria de salud en una Unidad Básica de Salud en Brasil. Materiales y método: estudio de cohorte prospectivo, realizado en domicilios y en unidades de atención primaria de salud. En la primera oleada, prepandémica, la muestra estaba formada por ancianos no frágiles (n = 168). Tras un seguimiento medio de 762 días, se llevo a cabo una segunda etapa, en la que se clasifico a los ancianos en función de su nivel de exposición al distanciamiento social y al aislamiento (n = 100), así como de los resultados “nivel de actividad física” y “estado de fragilidad”. Se utilizaron cuestionarios sociodemográficos y clínicos, miniexamen del estado mental, marcadores de fragilidad física y grado de adhesión al distanciamiento y el aislamiento social. Se realizaron estadísticas descriptivas, análisis de asociación, curvas de supervivencia y regresión de riesgos proporcionales. Resultados: el 53 % de los ancianos pasaron a la situación de prefragilidad y el 21 % mostraron una disminución de la actividad física. Hubo un alto porcentaje de baja adherencia al distanciamiento social y al aislamiento, y no hubo asociación con la actividad física y la fragilidad (p = 0,288; p = 0,351, respectivamente). Las mujeres tenían un mayor riesgo de ser clasificadas como pre-frágiles o frágiles (2,53; IC 95 %, 1,01-6,34) y de mostrar una disminucion de la actividad fisica (2,13; IC 95 %, 1,06-4,26). Conclusión: no hubo asociación entre las medidas protectoras de distanciamiento social y aislamiento, actividad física y fragilidad. Se debería animar a los ancianos con un nivel reducido de actividad física a practicarla para mantenerse activos y evitar la transición a la fragilidad, la perdida de funcionalidad y la dependencia.

Resumo Introdução: a associação entre a diminuição da atividade física e o isolamento social já foi descrita na literatura, entretanto a relação do nível de adesão dos idosos às medidas protetivas durante a pandemia da covid-19 e os efeitos ocasionados pela inatividade física na condição de fragilidade permanece com expressivo hiato de conhecimento. Objetivo: analisar os efeitos do distanciamento e do isolamento sociais gerados pela pandemia da covid-19 na fragilidade em idosos e nas atividades físicas realizadas por eles da atenção primária à saúde de uma Unidade Básica de Saúde do Brasil. Materiais e método: estudo de coorte prospectivo, realizado nos domicílios e em unidades básicas de saúde. Na primeira onda, pré-pandemia, a amostra foi composta por idosos (n = 168) não frágeis. Após o seguimento médio de 762 dias, realizou-se uma segunda onda, em que se classificaram os idosos conforme o nível de exposição ao distanciamento e ao isolamento sociais (n = 100), bem como se observaram os desfechos “nível de atividade física” e “condição de fragilidade”. Aplicaram-se questionários sociodemográfico e clínico, miniexame do estado mental, marcadores de fragilidade física e grau de adesão ao distanciamento e ao isolamento sociais. Realizaram se análises estatísticas descritivas, de associação, curvas de sobrevida e regressão de riscos proporcionais. Resultados: 53 % dos idosos transicionaram para a pré-fragilidade e 21 % apresentaram diminuição de atividade física. Houve elevado percentual de baixo grau de adesão ao distanciamento e ao isolamento sociais, e não se observou associação com atividade física e fragilidade (p = 0,288; p = 0,351, respectivamente). Mulheres tiveram mais risco de se classificarem como pré-frágeis ou frágeis (2,53; IC 95 %, 1,01-6,34) e de apresentarem diminuição de atividade física (2,13; IC 95 %, 1,06-4,26). Conclusão: não houve associação entre medidas protetivas de distanciamento e isolamento social, atividade física e fragilidade. Idosos que apresentam redução do nível de atividade física devem ser estimulados à sua prática a fim de se manterem ativos e se evitar a transição para a fragilidade, para a perda de funcionalidade e para a dependência.

ABSTRACT Objective: To evaluate autoinflammatory diseases (AID) according to age at diagnosis and sex, and response to therapy in a large population. Methods: This is a cross-sectional observational study of a Latin American registry using a designed web system for data storage, collected between 2015 and 2018. Any altered findings during follow-up were recorded. The forms were translated into Portuguese and Spanish, including demographic, clinical, laboratory, genetic and treatment characteristics. Results: We included 152 patients, 51.3% male and 75% Caucasian. The median age at disease onset was 2.1 years (0–15.6 years) and median age at diagnosis 6.9 years (0–21.9 years); 111 (73%) were children (0–9 years old), and 41 (27%) were adolescents and young adults (AYA) (10–21 years old). Periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome (PFAPA) occurred in 46/152 (30%), chronic non-bacterial osteomyelitis (CNO) in 32/152 (21%), and familial Mediterranean fever (FMF) in 24/152 (15.7%). PFAPA was significantly higher in young children than in AYA (38.7% vs. 7.3%, p<0.001), while CNO were lower (13.5% vs. 41.5%, p<0.001). The frequency of females was significantly higher in CNO (28.4% vs. 14.1%, p=0.031) and lower in FMF (8.1% vs. 23.1%, p=0.011). The most used drugs were glucocorticoids, non-steroidal anti-inflammatory drugs (NSAID), and colchicine. Glucocorticoids and colchicine treatment were used in all AID with good to moderate response. However, cryopyrin-associated periodic syndromes (CAPS) seemed unresponsive to glucocorticoids. NSAIDs and methotrexate were the main medications used to treat CNO. Conclusions: Differences among AID patients were observed in the LA population regarding sex and age at disease diagnosis. Objective (AID Methods crosssectional cross sectional storage 201 2018 followup follow up recorded Spanish demographic clinical laboratory characteristics Results 15 513 51 3 51.3 75 Caucasian 21 2 1 2. 0–15.6 0156 0 6 (0–15. 69 9 6. 0–21.9 0219 (0–21. 11 73% 73 (73% 0–9 09 (0– old, old , old) 4 27% 27 (27% (AYA 10–21 1021 10 (10–2 old. . stomatitis pharyngitis (PFAPA 46152 46 46/15 30%, 30 30% (30%) nonbacterial non bacterial (CNO 32152 32 32/15 21%, 21% (21%) (FMF 24152 24 24/15 15.7%. 157 15.7% 7 (15.7%) 38.7% 387 38 (38.7 vs 7.3% p<0.001, p0001 p p<0.001 001 p<0.001) 13.5% 135 13 5 (13.5 415 41.5% p<0.001. 28.4% 284 28 (28.4 141 14 14.1% p=0.031 p0031 031 8.1% 81 8 (8.1 231 23 23.1% p=0.011. p0011 p=0.011 011 p=0.011) glucocorticoids nonsteroidal steroidal antiinflammatory anti inflammatory NSAID, NSAID (NSAID) However cryopyrinassociated cryopyrin associated CAPS (CAPS Conclusions 20 51. 0–15. 015 (0–15 0–21. 021 (0–21 (73 0– (0 (27 10–2 102 (10– 4615 46/1 (30% 3215 32/1 (21% 2415 24/1 15.7 (15.7% 38.7 (38. 7.3 p000 p<0.00 00 13.5 (13. 41.5 28.4 (28. 14.1 p=0.03 p003 03 8.1 (8. 23.1 p001 p=0.01 01 (NSAID 0–15 (0–1 0–21 02 (0–2 (7 ( (2 10– (10 461 46/ (30 321 32/ (21 241 24/ 15. (15.7 38. (38 7. p00 p<0.0 13. (13 41. 28. (28 14. p=0.0 8. (8 23. 0–1 0–2 (1 (3 (15. p0 p<0. p=0. (15 p<0 p=0 p< p=

RESUMO Objetivo: Avaliar as doenças autoinflamatórias (DAI) de acordo com sexo e idade no momento do diagnóstico e a resposta terapêutica em uma grande população. Métodos: Este é um estudo observacional transversal de um registro latino-americano que usou um sistema de dados coletados entre 2015 e 2018. Quaisquer achados alterados ao longo do acompanhamento foram registrados. Os formulários foram traduzidos para os idiomas português e espanhol, incluindo características demográficas, clínicas, laboratoriais, genéticas e de tratamento. Resultados: Incluímos 152 pacientes, sendo 51,3% do sexo masculino e 75% da raça branca. A média de idade de início da doença foi de 2,1 anos (0–15,6 anos) e a média de idade de diagnóstico 6,9 anos (0–21,9 anos); 111 (73%) eram crianças (0–9 anos) e 41 (27%) adolescentes/adultos jovens (10–21 anos). A síndrome de febre periódica, estomatite aftosa, faringite e adenite (PFAPA) ocorreu em 46/152 (30%), osteomielite não bacteriana crônica (CNO) em 32/152 (21%) e febre familiar do Mediterrâneo (FMF) em 24/152 (15,7%). A PFAPA foi significativamente maior em crianças pequenas (38,7 vs. 7,3%, p<0,001), e a CNO, em adolescentes/adultos jovens (13,5 vs. 41,5%, p<0,001). A frequência do sexo feminino foi significativamente maior na CNO (28,4 vs. 14,1%, p=0,031) e menor na FMF (8,1 vs. 23,1%, p=0,011). Os medicamentos mais utilizados foram glicocorticoides, anti-inflamatórios não esteroidais (AINE) e colchicina. O tratamento com glicocorticoides e colchicina foi usado em todas as DAI com resposta boa a moderada. No entanto, as síndromes periódicas associadas à criopirina (CAPS) pareciam não responder aos glicocorticoides. AINE e metotrexato foram os principais medicamentos utilizados no tratamento da CNO. Conclusões: Diferenças de pacientes com DAI foram observadas na população latino-americana em pacientes agrupados por sexo e idade ao diagnóstico da doença. Objetivo (DAI Métodos latinoamericano latino americano 201 2018 registrados espanhol demográficas clínicas laboratoriais Resultados 15 513 51 3 51,3 75 branca 21 2 1 2, 0–15,6 0156 0 6 (0–15, 69 9 6, 0–21,9 0219 (0–21, 11 73% 73 (73% 0–9 09 (0– 4 27% 27 (27% adolescentesadultos adolescentes adultos 10–21 1021 10 (10–2 anos. . periódica aftosa (PFAPA 46152 46 46/15 30%, 30 30% , (30%) (CNO 32152 32 32/15 21% (21% (FMF 24152 24 24/15 15,7%. 157 15,7% 7 (15,7%) 38,7 387 38 (38, vs 7,3% p<0,001, p0001 p p<0,001 001 p<0,001) 13,5 135 13 5 (13, 415 41,5% p<0,001. 28,4 284 28 (28, 141 14 14,1% p=0,031 p0031 031 8,1 81 8 (8, 231 23 23,1% p=0,011. p0011 p=0,011 011 p=0,011) antiinflamatórios anti inflamatórios (AINE moderada entanto CAPS (CAPS Conclusões latinoamericana americana 20 51, 0–15, 015 (0–15 0–21, 021 (0–21 (73 0– (0 (27 10–2 102 (10– 4615 46/1 (30% 3215 32/1 (21 2415 24/1 15,7 (15,7% 38, (38 7,3 p000 p<0,00 00 13, (13 41,5 28, (28 14,1 p=0,03 p003 03 8, (8 23,1 p001 p=0,01 01 0–15 (0–1 0–21 02 (0–2 (7 ( (2 10– (10 461 46/ (30 321 32/ 241 24/ 15, (15,7 (3 7, p00 p<0,0 (1 41, 14, p=0,0 23, 0–1 0–2 (15, p0 p<0, p=0, (15 p<0 p=0 p< p=

Abstract Background Increased malignancy frequency is well documented in adult-systemic lupus erythematosus (SLE), but with limited reports in childhood-onset SLE (cSLE) series. We explored the frequency of malignancy associated with cSLE, describing clinical and demographic characteristics, disease activity and cumulative damage, by the time of malignancy diagnosis. Method A retrospective case-notes review, in a nationwide cohort from 27 Pediatric Rheumatology centres, with descriptive biopsy-proven malignancy, disease activity/damage accrual, and immunosuppressive treatment were compiled in each participating centre, using a standard protocol. Results Of the 1757 cSLE cases in the updated cohort, 12 (0.7%) developed malignancy with median time 10 years after cSLE diagnosis. There were 91% females, median age at cSLE diagnosis 12 years, median age at malignancy diagnosis 23 years. Of all diagnosed malignancies, 11 were single-site, and a single case with concomitant multiple sites; four had haematological (0.22%) and 8 solid malignancy (0.45%). Median (min–max) SLEDAI-2 K scores were 9 (0–38), median (min–max) SLICC/ACR-DI (SDI) score were 1 (1–5) Histopathology defined 1 Hodgkin's lymphoma, 2 non-Hodgkin's lymphoma, 1 acute lymphoblastic leukaemia; 4 gastrointestinal carcinoma, 1 squamous cell carcinoma of the tongue and 1 anal carcinoma; 1 had sigmoid adenocarcinoma and 1 stomach carcinoid; 3 had genital malignancy, being 1 vulvae, 1 cervix and 1 vulvae and cervix carcinomas; 1 had central nervous system oligodendroglioma; and 1 testicle germ cell teratoma. Conclusion Estimated malignancy frequency of 0.7% was reported during cSLE follow up in a multicentric series. Median disease activity and cumulative damage scores, by the time of malignancy diagnoses, were high; considering that reported in adult series. adultsystemic systemic SLE, , (SLE) childhoodonset childhood onset (cSLE series characteristics casenotes notes review centres biopsyproven biopsy proven activitydamage accrual centre protocol 175 07 0 7 (0.7% 91 females malignancies singlesite, singlesite site, site single-site sites 0.22% 022 22 (0.22% 0.45%. 045 0.45% . 45 (0.45%) min–max minmax min max (min–max SLEDAI2 SLEDAI SLEDAI- 0–38, 038 0–38 38 (0–38) SLICC/ACRDI SLICCACRDI SLICC/ACR DI SLICC ACR SDI (SDI 1–5 15 5 (1–5 Hodgkins Hodgkin s lymphoma nonHodgkins non leukaemia carcinoid carcinomas oligodendroglioma teratoma 0.7 diagnoses high (SLE 17 (0.7 0.22 02 (0.22 04 0.45 (0.45% 03 0–3 (0–38 ACRDI SLICCACR 1– (1– 0. (0. 0.2 (0.2 0.4 (0.45 0– (0–3 (1 (0 (0.4 (0– (

abstract The objective of this work is to analyze transformer-based machine translation models. It aims to test the feasibility of using trained models based on specialized corpus. For the training of such model, a parallel English-French corpus was built with seven texts related to the Convention of 25 October 1980 on the Civil Aspects of International Child Abduction. The translation results obtained by the trained model were compared with those produced by Google Translate. For the evaluation stage, sacreBLEU automatic evaluation and human evaluation methods were used. The outcome of the automatic evaluation of sentences produced by the trained model was, on average, higher than those generated by the non-trained model. The human evaluation of the sentences revealed that there were adequacy errors in the use of language specific to the subject matter of the 1980 Hague Convention both in sentences generated by the trained model and in sentences generated by the Google Translate model. transformerbased transformer EnglishFrench English French 2 198 Abduction stage used average nontrained non 19 1

Resumo O presente trabalho possui como objetivo a análise dos modelos de tradução automática baseados em Transformer. Em específico, a pesquisa visa ao teste da viabilidade do uso de modelos treinados a partir de corpus especializado. Para o treinamento do modelo, foi construído um corpus paralelo inglês-francês a partir de sete textos da Convenção de 25 de outubro de 1980 sobre os Aspectos Civis do Rapto Internacional de Crianças. Os resultados de tradução obtidos pelo modelo treinado foram comparados com aqueles produzidos pelo Google Tradutor. Para a etapa de avaliação foram utilizados os métodos de avaliação automática sacreBLEU e avaliação humana. Os resultados da avaliação automática de frases produzidas pelo modelo treinado foram, em média, mais positivos que aqueles gerados pelo modelo não treinado. A avaliação humana das frases revelou que houve erros de adequação no uso da linguagem específica à matéria da Convenção da Haia de 1980 tanto em frases geradas pelo modelo treinado, quanto em frases geradas pelo modelo do Google Tradutor. Transformer específico especializado inglêsfrancês inglês francês 2 198 Crianças Tradutor média 19 1

ABSTRACT Objective: To review the pathological diagnosis of possible cases and/or hidden cases of malignant mesothelioma (MM) between 2000 and 2012 using the Hospital-Based Cancer Registry database in the state of São Paulo, Brazil. Methods: Possible cases were retrieved by assessing the database. Inclusion criteria were being older than 30 years of age and having ICD-O-3 topography and morphology codes related to MM. A board of expert pathologists reviewed the pathology reports and requested paraffin blocks in cases that demanded revision. After staining with calretinin, D2-40, WT-1 (as positive MM markers) and Ber-EP4 and MOC31 (as negative MM markers), cases were divided and studied independently by a pair of pathologists to confirm or discard the diagnosis of MM. Results: Our sample comprised 482 cases from 25 hospitals, and 130 needed further histological revision. We received 73 paraffin blocks with adequate material. After board analysis, there were 9 cases with a definitive diagnosis of MM, improving the diagnostic rate in 12%. Two cases of previously diagnosed MM were discarded by review. Conclusions: Our results confirm that part of MM underdiagnosis and underreporting in Brazil is due to incomplete or mistaken pathological diagnosis. Objective andor (MM 200 201 HospitalBased Hospital Based Paulo Methods 3 ICDO3 ICDO ICD O ICD-O- revision calretinin D240, D240 D D2 40, 40 D2-40 WT1 WT 1 WT- as markers BerEP4 BerEP Ber EP4 EP Ber-EP MOC MOC3 markers, , Results 48 2 hospitals 13 7 material analysis 12 12% Conclusions 20 ICD-O D24 4 D2-4 D2-

ABSTRACT Late sowings anticipate flowering and decrease the soybean vegetative plasticity. These changes may limit the ability of plants to tolerate leaf area losses. The objective of this research was to evaluate the sowing date effect on soybean tolerance to defoliation at the beginning of pod formation. The experiment was set in Lages (Santa Catarina State, Brazil) during the 2016/2017 growing season. Two sowing dates were tested: November 2, 2016 (preferential) and December 15, 2016 (late). Five levels of defoliation (0%, 17%, 33%, 50% and 67%) of cultivar NA 5909 RG were imposed at the R3 growth stage. Grain yield showed a quadratic response to defoliation, ranging from 4,313 to 6,478 kg ha-1 in the preferential sowing date and from 3,374 to 4,443 kg ha-1 in the late sowing date. The plants tolerated up to 45.6% of defoliation in early sowing and 55.8% in late sowing, without yield losses, in comparison to the control. The highest level of defoliation reduced grain yield by 26.9% and 13.4% in early and late sowings, respectively, compared to the control. The delay of sowing date did not increase the sensitivity of cultivar NA 5909 RG to defoliation at the beginning of pod formation. plasticity losses formation Santa State Brazil 20162017 2017 2016/201 season tested 2 201 (preferential 15 late. . (late) 0%, 0 (0% 17 17% 33 33% 50 67% 67 590 R stage 4313 4 313 4,31 6478 6 478 6,47 ha1 ha 1 ha- 3374 3 374 3,37 4443 443 4,44 456 45 45.6 558 55 8 55.8 control 269 26 9 26.9 134 13 13.4 respectively 2016201 2016/20 20 (late 0% (0 5 59 431 31 4,3 647 47 6,4 337 37 3,3 444 44 4,4 45. 55. 26. 13. 201620 2016/2 ( 43 4, 64 6, 3, 20162 2016/

RESUMO: Objetivo: investigar a relação da procalcitonina no diagnóstico diferencial de coinfecção bacteriana em pacientes com Covid-19. Método: estudo transversal retrospectivo, realizado em unidade de terapia intensiva em hospital público do sul do Brasil, entre fevereiro e março de 2021, mediante formulário. Realizaram-se análises estatísticas descritivas e de associação entre variáveis. Resultados: dos 231 pacientes, 28,14% apresentaram infecção, 63,20% de sítio pulmonar, em 25% ocorreu isolamento de bactérias, 77,49% utilizaram antimicrobianos e em 14,72% dos casos foi observada procalcitonina > dois ng/mL. Houve associação significativa entre uso de antimicrobiano e infeção (p=0,001), isolamento de bactérias (p<0,001), topografia da infeção (p<0,001), valores de procalcitonina (p<0,001). O uso da procalcitonina mostrou associação com infeção bacteriana (p<0,001), isolamento de bactéria (p<0,001), uso de antimicrobianos (p=0,001), e óbito (p<0,001). Conclusão: a procalcitonina pode reduzir o uso empírico de antimicrobianos e estimular a detecção e identificação de patógenos, levando em consideração os dados clínicos e epidemiológicos. RESUMO Objetivo Covid19. Covid19 Covid 19. 19 Covid-19 Método retrospectivo Brasil 2021 formulário Realizaramse Realizaram se variáveis Resultados 23 2814 28 14 28,14 infecção 6320 63 20 63,20 pulmonar 25 7749 77 49 77,49 1472 72 14,72 ngmL ng mL ng/mL p=0,001, p0001 p p=0,001 , 0 001 (p=0,001) p<0,001, p<0,001 (p<0,001) p<0,001. . Conclusão patógenos epidemiológicos Covid1 1 Covid-1 202 2 281 28,1 632 6 63,2 774 7 4 77,4 147 14,7 p000 p=0,00 00 (p=0,001 p<0,00 (p<0,001 Covid- 28, 63, 77, 14, p00 p=0,0 (p=0,00 p<0,0 (p<0,00 p0 p=0, (p=0,0 p<0, (p<0,0 p=0 (p=0, p<0 (p<0, p= (p=0 p< (p<0 (p= (p< (p

ABSTRACT Objective: to investigate the relationship between procalcitonin in the differential diagnosis of bacterial coinfection in COVID-19 patients. Method: a cross-sectional retrospective study conducted between February and March 2021 in the Intensive Care Unit of a public hospital from southern Brazil by filling in a form. Descriptive statistical analyses were performed, as well as of association between variables. Results: of the 231 patients, 28.14% presented infection (63.20% in the lungs), 25% had bacteria isolated, 77.49% used antimicrobials and, in 14.72% of the cases, procalcitonin > 2 ng/mL. There was a significant association between antimicrobial use and infection (p=0.001), isolation of bacteria (p<0.001), topography of the infection (p<0.001) and procalcitonin values (p<0.001). Procalcitonin use showed an association with bacterial infection (p<0.001), isolation of bacteria (p<0.001), antimicrobial use (p=0.001) and death (p<0.001). Conclusion: procalcitonin can reduce empirical antimicrobial use and stimulate detection and identification of pathogens, taking into account the clinical and epidemiological data. Objective COVID19 COVID 19 COVID-1 patients Method crosssectional cross sectional 202 form performed variables Results 23 2814 28 14 28.14 63.20% 6320 63 20 (63.20 lungs, lungs , lungs) 25 isolated 7749 77 49 77.49 1472 72 14.72 cases ngmL ng mL ng/mL p=0.001, p0001 p p=0.001 0 001 p<0.001, p<0.001 (p<0.001 p<0.001. . (p=0.001 Conclusion pathogens data COVID1 1 COVID- 281 28.1 63.20 632 6 (63.2 774 7 4 77.4 147 14.7 p000 p=0.00 00 p<0.00 (p<0.00 (p=0.00 28. 63.2 (63. 77. 14. p00 p=0.0 p<0.0 (p<0.0 (p=0.0 63. (63 p0 p=0. p<0. (p<0. (p=0. (6 p=0 p<0 (p<0 (p=0 ( p= p< (p< (p= (p

RESUMEN Objetivo: investigar la relación de la procalcitonina en el diagnóstico diferencial de coinfección bacteriana en pacientes con COVID-19. Método: estudio transversal y retrospectivo realizado entre febrero y marzo de 2021 en la unidad de cuidados intensivos de un hospital público del sur de Brasil, por medio de un formulario. Se realizaron análisis estadísticos descriptivos y de asociación entre variables. Resultados: de los 231 pacientes, el 28,14% presentó infección (el 63,20% en los pulmones), en el 25% se aislaron las bacterias, el 77,49% utilizó antimicrobianos y en el 14,72% de los casos se empleó procalcitonina > 2 ng/mL. Hubo una significativa asociación entre uso de antimicrobianos e infección (p=0,001), aislamiento de bacterias (p<0,001), topografía de la infección (p<0,001) y valores de procalcitonina (p<0,001). La utilización de procalcitonina demostró estar asociada con infección bacteriana (p<0,001), aislamiento de bacterias (p<0,001), uso de antimicrobianos (p=0,001) y fallecimiento (p<0,001). Conclusión: la procalcitonina puede reducir el uso empírico de antimicrobianos y estimular la detección e identificación de patógenos, considerando los datos clínicos y empíricos. Objetivo COVID19. COVID19 COVID 19. 19 COVID-19 Método 202 Brasil formulario variables Resultados 23 2814 28 14 28,14 6320 63 20 63,20 pulmones, pulmones , pulmones) 25 7749 77 49 77,49 1472 72 14,72 ngmL ng mL ng/mL p=0,001, p0001 p p=0,001 0 001 p<0,001, p<0,001 (p<0,001 p<0,001. . (p=0,001 Conclusión patógenos empíricos COVID1 1 COVID-1 281 28,1 632 6 63,2 774 7 4 77,4 147 14,7 p000 p=0,00 00 p<0,00 (p<0,00 (p=0,00 COVID- 28, 63, 77, 14, p00 p=0,0 p<0,0 (p<0,0 (p=0,0 p0 p=0, p<0, (p<0, (p=0, p=0 p<0 (p<0 (p=0 p= p< (p< (p= (p

Abstract Background Data on post-acute COVID-19 in autoimmune rheumatic diseases (ARD) are scarce, focusing on a single disease, with variable definitions of this condition and time of vaccination. The aim of this study was to evaluate the frequency and pattern of post-acute COVID-19 in vaccinated patients with ARD using established diagnosis criteria. Methods Retrospective evaluation of a prospective cohort of 108 ARD patients and 32 non-ARD controls, diagnosed with SARS-CoV-2 infection (RT-PCR/antigen test) after the third dose of the CoronaVac vaccine. Post-acute COVID-19 (≥ 4 weeks and > 12 weeks of SARS-CoV-2 symptoms) were registered according to the established international criteria. Results ARD patients and non-ARD controls, balanced for age and sex, had high and comparable frequencies of ≥ 4 weeks post-acute COVID-19 (58.3% vs. 53.1%, p = 0.6854) and > 12 weeks post-acute COVID-19 (39.8% vs. 46.9%, p = 0.5419). Regarding ≥ 4 weeks post-acute COVID-19, frequencies of ≥ 3 symptoms were similar in ARD and non-ARD controls (54% vs. 41.2%, p = 0.7886), and this was also similar in > 12 weeks post-acute COVID-19 (68.3% vs. 88.2%, p = 0.1322). Further analysis of the risk factors for ≥ 4 weeks post-acute COVID-19 in ARD patients revealed that age, sex, clinical severity of COVID-19, reinfection, and autoimmune diseases were not associated with this condition (p > 0.05). The clinical manifestations of post-acute COVID-19 were similar in both groups (p > 0.05), with fatigue and memory loss being the most frequent manifestations. Conclusion We provide novel data demonstrating that immune/inflammatory ARD disturbances after third dose vaccination do not seem to be a major determinant of post-acute COVID-19 since its pattern is very similar to that of the general population. Clinical Trials platform (NCT04754698). postacute post acute COVID19 COVID 19 COVID-1 (ARD scarce disease criteria 10 nonARD non SARSCoV2 SARSCoV SARS CoV 2 SARS-CoV- RTPCR/antigen RTPCRantigen RT PCR/antigen PCR antigen test vaccine Postacute Post ( 1 sex 58.3% 583 58 (58.3 vs 531 53 53.1% 0.6854 06854 0 6854 39.8% 398 39 8 (39.8 469 46 9 46.9% 0.5419. 05419 0.5419 . 5419 0.5419) COVID19, 19, 54% 54 (54 412 41 41.2% 0.7886, 07886 0.7886 , 7886 0.7886) 68.3% 683 68 (68.3 882 88 88.2% 0.1322. 01322 0.1322 1322 0.1322) reinfection 0.05. 005 0.05 05 0.05) 0.05, immuneinflammatory immune inflammatory population NCT04754698. NCT04754698 NCT (NCT04754698) COVID1 COVID- SARS-CoV RTPCR PCRantigen 58.3 5 (58. 53.1 0.685 0685 685 39.8 (39. 46.9 0541 0.541 541 (5 41.2 0788 0.788 788 68.3 6 (68. 88.2 0132 0.132 132 00 0.0 NCT0475469 (NCT04754698 58. (58 53. 0.68 068 39. (39 46. 054 0.54 41. 078 0.78 78 68. (68 88. 013 0.13 13 0. NCT047546 (NCT0475469 0.6 06 (3 0.5 07 0.7 7 (6 01 0.1 NCT04754 (NCT047546 NCT0475 (NCT04754 NCT047 (NCT0475 NCT04 (NCT047 NCT0 (NCT04 (NCT0 (NCT

RESUMEN Objetivo Analizar la relación entre la hospitalización y la aparición de delirio en adultos mayores con fragilidad física. Método Estudio transversal realizado en un hospital público del sur de Brasil. Participaron adultos mayores hospitalizados con edad ≥ 60 años. Se recogieron datos sociodemográficos y clínicos, se realizaron pruebas de fenotipo de fragilidad física y se utilizó el Confusion Assessment Method. Se realizaron análisis descriptivos y se estimaron los odds ratio para las variables fragilidad y delirio. Resultados De los 320 adultos mayores evaluados, el 21,14% presentó delirio, el 49% fueron identificados como prefrágiles y el 36,2% como frágiles. De los adultos mayores afectados por delirio, el 71,6% fueron clasificados como frágiles y el 28,3% como prefrágiles (p < 0,001). Se observó asociación entre la aparición de delirio y fragilidad (OR 1,22; IC 95% 1,07 a 1,38), edad ≥ 80 años (OR 1,14; IC 95% 1,01 a 1,32), epilepsia (OR 1,38; IC 95% 1,09 a 1,76), demencia (OR 1,58; IC del 95%: 1,37 a 1,82) y antecedentes de accidente cerebrovascular (OR 1,14; IC del 95%: 1,03 a 1,26). Conclusión Hubo una alta frecuencia de adultos mayores prefrágiles y frágiles y la aparición de delirio en los frágiles fue significativamente mayor. Se debe prestar especial atención a los adultos mayores frágiles para prevenir la aparición de delirio durante la hospitalización. Brasil 6 clínicos Method 32 evaluados 2114 21 14 21,14 49 362 36 2 36,2 716 71 71,6 283 28 3 28,3 p 0,001. 0001 0,001 . 0 001 0,001) OR 1,22 122 1 22 95 107 07 1,0 1,38, 138 1,38 , 38 1,38) 8 1,14 114 101 01 1,32, 132 1,32 1,32) 109 09 1,76, 176 1,76 76 1,76) 1,58 158 58 137 37 1,3 1,82 182 82 103 03 1,26. 126 1,26 26 1,26) mayor 211 21,1 4 36, 7 71, 28, 000 0,00 00 1,2 12 9 10 1, 13 1,1 11 17 1,7 1,5 15 5 1,8 18 21, 0,0 0,

ABSTRACT Objective To analyze the relationship between hospitalization and the occurrence of delirium in older adults with physical frailty. Method Cross-sectional study carried out in a public hospital in southern Brazil. Hospitalized older adults aged ≥ 60 years participated. Sociodemographic and clinical data were collected, physical frailty phenotype tests were performed and the Confusion Assessment Method was used. Descriptive analyzes were carried out and odds ratio values were estimated for the frailty and delirium variables. Results Of the 320 older adults evaluated, 21.14% presented delirium, 49% were identified as pre-frail and 36.2% as frail. Of those affected by delirium, 71.6% were classified as frail and 28.3% as pre-frail (p < 0.001). An association was observed between the occurrence of delirium and frailty (OR 1.22; 95% CI 1.07 to 1.38), age ≥ 80 years (OR 1.14; 95% CI 1.01 to 1.32), epilepsy (OR 1.38; 95% CI 1.09 to 1.76), dementia (OR 1.58; 95% CI 1.37 to 1.82), and history of stroke (OR 1.14; 95% CI 1.03 to 1.26). Conclusion There was a high frequency of pre-frail and frail older adults, and the occurrence of delirium in frail was significantly higher. Special attention should be paid to frail older adults to prevent the occurrence of delirium during hospitalization. Crosssectional Cross sectional Brazil 6 participated collected used variables 32 evaluated 2114 21 14 21.14 49 prefrail pre 362 36 2 36.2 716 71 71.6 283 28 3 28.3 p 0.001. 0001 0.001 . 0 001 0.001) OR 1.22 122 1 22 95 107 07 1.0 1.38, 138 1.38 , 38 1.38) 8 1.14 114 101 01 1.32, 132 1.32 1.32) 109 09 1.76, 176 1.76 76 1.76) 1.58 158 58 137 37 1.3 1.82, 182 1.82 82 1.82) 103 03 1.26. 126 1.26 26 1.26) higher 211 21.1 4 36. 7 71. 28. 000 0.00 00 1.2 12 9 10 1. 13 1.1 11 17 1.7 1.5 15 5 18 1.8 21. 0.0 0.

RESUMO Objetivo Analisar a relação entre hospitalização e ocorrência de delirium em idosos na condição de fragilidade física. Método Estudo transversal desenvolvido em hospital público no Sul do Brasil. Participaram idosos hospitalizados, idade ≥ 60 anos. Foram coletados dados sociodemográficos e clínicos, e feitos testes do fenótipo da fragilidade física, bem como o Confusion Assessment Method. Realizaram-se análises descritivas e estimaram-se as odds ratio para as variáveis fragilidade e delirium. Resultados Dos 320 idosos avaliados, 21,14% apresentaram delirium, 49% foram identificados como pré-frágeis e 36,2% frágeis. Dos idosos acometidos por delirium, 71,6% foram classificados como frágeis e 28,3% pré-frágeis (p< 0,001). Observou-se associação entre ocorrência de delirium e fragilidade (OR 1,22; IC 95% 1,07 a 1,38), idade ≥ 80 anos (OR 1,14; IC 95% 1,01 a 1,32), epilepsia (OR 1,38; IC 95% 1,09 a 1,76), demência (OR 1,58; IC 95% 1,37 a 1,82), e história de acidente vascular encefálico (OR 1,14; IC 95% 1,03 a 1,26). Conclusão Observou-se alta frequência de idosos pré-frágeis e frágeis e ocorrência de delirium expressivamente maior nos frágeis. Atenção especial deve ser empregada a idosos frágeis para prevenir a ocorrência de delirium durante a hospitalização. física Brasil hospitalizados 6 clínicos Method Realizaramse Realizaram se estimaramse estimaram variaveis varia veis 32 avaliados 2114 21 14 21,14 49 préfrágeis pré 362 36 2 36,2 716 71 71,6 283 28 3 28,3 p< p (p 0,001. 0001 0,001 . 0 001 0,001) Observouse Observou OR 1,22 122 1 22 95 107 07 1,0 1,38, 138 1,38 , 38 1,38) 8 1,14 114 101 01 1,32, 132 1,32 1,32) 109 09 1,76, 176 1,76 76 1,76) 1,58 158 58 137 37 1,3 1,82, 182 1,82 82 1,82) historia histo ria 103 03 1,26. 126 1,26 26 1,26) 211 21,1 4 36, 7 71, 28, 000 0,00 00 1,2 12 9 10 1, 13 1,1 11 17 1,7 1,5 15 5 18 1,8 21, 0,0 0,

Abstract Objective: To evaluate inactivated CoronaVac prime vaccination, antibody decay, booster dose, and safety in ANCA-Associated Vasculitis (AAV) patients. Methods: Fifty-three AAV patients and 106 Controls (CG) received CoronaVac on days: D0 (first dose), D28(second dose), and D210 (booster dose, 32 AAV: 32 CG). The primary outcome was immunogenicity after the second vaccine dose (day 69) assessed by Seroconversion Rates (SC) of anti-SARS-CoV-2 S1/S2 IgG and Neutralizing Antibodies (NAb). Secondary outcomes were safety, immunogenicity (D28/D240), 6-months antibody decay (D210) and the booster dose response (D240). Results: At D69 SC (65.1% vs. 96.8%, p = 0.0001), GMT (21.3 UA/mL vs. 67.7 UA/mL, p < 0.001) and NAb- positivity (53.7% vs. 80.6%, p = 0.001) were moderate but lower in naïve-AAV patients than CG. Patients without SC used more often IS (93.3% vs. 53.3%, p = 0.015), mycophenolate mofetil (20% vs. 0%, p = 0.037) and prednisone (60.0% vs. 28.6%, p = 0.057) than seroconverted. NAb negativity in AAV patients was associated with prednisone treatment (57.9% vs. 18.2%, p = 0.015) and IS (84.2% vs. 55.0%, p = 0.046). Logistic regression analysis models showed that only prednisone was associated with lower seroconversion (OR = 0.2, 0,95% CI 0.05–0.86, p = 0.030) and with lower NAb positivity (OR = 0.2, 0,95% CI 0.05–0.88, p = 0.034). After six months (D69–D210) a decrease in IgG positivity occurred in 32 AAV patients (15.7%, p = 0.074) and 32 CG (18.7%, p = 0.041). For the NAb positivity, the 6-month decrease was not significant (p = 0.114) whereas a major reduction occurred for CG (p < 0.001). A booster dose (D240) resulted in an increment in IgG-positivity (21.9%, p = 0.023) and NAb-positivity (34.4%, p = 0.006) in AAV patients. No moderate/severe adverse events attributable to the vaccine were observed. Conclusion: This study provides novel data on the excellent safety and moderate immunogenicity of CoronaVac in AAV patients. A six-month mild antibody waning was observed with a good response to the booster dose, although levels remained lower than CG (CoronavRheum-NCT04754698). Objective vaccination ANCAAssociated ANCA Associated (AAV Methods Fiftythree Fifty three 10 (CG days D first , dose) D28second Dsecond D28 D21 3 . CG) day 69 (SC antiSARSCoV2 antiSARSCoV anti SARS CoV 2 anti-SARS-CoV- S1S2 SS S1 S2 S S1/S NAb. (NAb) D28/D240, D28D240 DD D28/D240 D240 (D28/D240) 6months 6 (D210 D240. Results D6 65.1% 651 65 1 (65.1 vs 968 96 8 96.8% 0.0001, 00001 0.0001 0 0001 0.0001) 21.3 213 21 (21. UAmL UA mL 677 67 7 67. 0.001 001 53.7% 537 53 (53.7 806 80 80.6% naïveAAV naïve 93.3% 933 93 (93.3 533 53.3% 0.015, 0015 0.015 015 20% 20 (20 0% 0.037 0037 037 60.0% 600 60 (60.0 286 28 28.6% 0.057 0057 057 seroconverted 57.9% 579 57 9 (57.9 182 18 18.2% 84.2% 842 84 (84.2 550 55 55.0% 0.046. 0046 0.046 046 0.046) OR 02 0.2 095 95 0,95 005086 05 86 0.05–0.86 0.030 0030 030 005088 88 0.05–0.88 0.034. 0034 0.034 034 0.034) D69–D210 D69D210 (D69–D210 15.7%, 157 15 (15.7% 0.074 0074 074 18.7%, 187 (18.7% 0.041. 0041 0.041 041 0.041) 6month month 0.114 0114 114 0.001. (D240 IgGpositivity 21.9%, 219 (21.9% 0.023 0023 023 NAbpositivity 34.4%, 344 34 4 (34.4% 0.006 0006 006 moderatesevere severe Conclusion sixmonth CoronavRheumNCT04754698. CoronavRheumNCT04754698 CoronavRheumNCT CoronavRheum NCT04754698 NCT (CoronavRheum-NCT04754698) D2 anti-SARS-CoV S1S (NAb D28D24 D28/D24 D24 (D28/D240 (D21 65.1 (65. 96.8 0000 0.000 000 21. (21 0.00 00 53.7 5 (53. 80.6 93.3 (93. 53.3 0.01 01 (2 0.03 003 03 60.0 (60. 28.6 0.05 005 57.9 (57. 18.2 84.2 (84. 55.0 004 0.04 04 0. 09 0,9 00508 0.05–0.8 D69–D21 D69D21 (D69–D21 15.7% (15.7 0.07 007 07 18.7% (18.7 0.11 011 11 (D24 21.9% (21.9 0.02 002 34.4% (34.4 CoronavRheumNCT0475469 NCT0475469 (CoronavRheum-NCT04754698 D28D2 D28/D2 (D28/D24 (D2 65. (65 96. 0.0 53. (53 80. 93. (93 ( 60. (60 28. 57. (57 18. 84. (84 55. 0, 0050 0.05–0. D69–D2 D69D2 (D69–D2 15.7 (15. 18.7 (18. 0.1 21.9 34.4 (34. CoronavRheumNCT047546 NCT047546 (CoronavRheum-NCT0475469 D28D D28/D (D28/D2 (D (6 (5 (9 (8 0.05–0 D69–D D69D (D69–D 15. (15 (18 34. (34 CoronavRheumNCT04754 NCT04754 (CoronavRheum-NCT047546 (D28/D 0.05– (1 (3 CoronavRheumNCT0475 NCT0475 (CoronavRheum-NCT04754 CoronavRheumNCT047 NCT047 (CoronavRheum-NCT0475 CoronavRheumNCT04 NCT04 (CoronavRheum-NCT047 CoronavRheumNCT0 NCT0 (CoronavRheum-NCT04 (CoronavRheum-NCT0 (CoronavRheum-NCT

Resumo Objetivo: Avaliar os parâmetros de saúde física e mental, de qualidade de vida relacionada à saúde (QVRS), em adolescentes com deficiência física matriculados em organização não governamental (ONG) esportiva vs. em adolescentes sem deficiência, durante a pandemia da doença do coronavírus 2019 (COVID-19). Métodos: Este estudo transversal incluiu 30 adolescentes com deficiência e 86 adolescentes sem deficiência que responderam a questionário online com dados sociodemográficos e informações de rotina de saúde autoavaliadas durante a quarentena da COVID-19. Versões validadas de autorrelato do Strengths and Difficulties Questionnaire (SDQ), Pediatric Quality of Life Inventory 4.0 (PedsQL4.0), Pittsburgh Sleep Quality Index (PSQI) e Pediatric Outcome Data Collection Instrument (PODCI) também foram aplicadas. Resultados: A mediana de problemas emocionais [4(0–10) vs. 5(0–10),p=0,018] e pró-social [7(0–10) vs. 9(3–10),p=0,006] foi menor em adolescentes com deficiência vs. adolescentes sem deficiência. Adolescentes com deficiência tiveram função global significantemente inferior [68(21–99) vs. 94(67–100),p <0,001] e pontuações de felicidade mais altas do PODCI [90(65–100) vs. 80(0–100),p=0,016] em comparação com o grupo sem deficiências. A análise de regressão logística demonstrou que a atividade física/semana (odds ratio — OR=1,03; intervalo de confiança — IC95%=1,01–1,05,p=0,002) foi maior nos adolescentes com deficiência. No entanto, atividades domésticas (OR=0,14; IC95%=0,04–0,43,p=0,001) e tempo de tela ≥3 horas/dia (OR=0,09; IC95%=0,02–0,38,p=0,001) foram menores nos adolescentes com deficiência. Conclusões: Os adolescentes com deficiência que frequentam uma organização não governamental (ONG) esportiva não tiveram maior risco de apresentar indicadores adversos à saúde; apesar de apresentarem função física reduzida, relataram mais atividade física, maior felicidade e menos tempo de tela em comparação com adolescentes sem deficiência durante a pandemia da COVID-19.

Abstract Objective: This study aimed to assess physical and mental health, and health-related quality of life (HRQL) parameters in adolescents with physical disabilities enrolled in a sports nongovernmental organization (NGO) versus adolescents without disabilities during coronavirus disease 2019 (COVID-19) pandemic. Methods: This cross-sectional study included 30 adolescents with disabilities and 86 adolescents without disabilities who responded to an online questionnaire with sociodemographic data and self-rated healthcare routine information during the COVID-19 quarantine. Validated self-report versions of the Strengths and Difficulties Questionnaire (SDQ), Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0), Pittsburgh Sleep Quality Index (PSQI), and Pediatric Outcome Data Collection Instrument (PODCI) were also applied. Results: The median of emotional [4 (0–10) vs. 5 (0–10), p=0.018] and prosocial [7 (0–10) vs. 9 (3–10), p=0.006] problems was lower in adolescents with disabilities versus adolescents without disabilities. Adolescents with disabilities had significantly lower global function [68 (21–99) vs. 94 (67–100), p<0.001] and higher happiness scores in the PODCI scale [90 (65–100) vs. 80 (0–100), p=0.016] compared to controls. Logistic regression analysis demonstrated that physical activity/week (OR=1.03; 95%CI 1.01–1.05, p=0.002) was higher in adolescents with disabilities compared to adolescents without disabilities. However, housework activities (OR=0.14; 95%CI 0.04–0.43, p=0.001) and screen time ≥3 h/day (OR=0.09; 95%CI 0.02–0.38, p=0.001) were lower in adolescents with disabilities compared to adolescents without disabilities. Conclusion: Adolescents with disabilities attending a sports NGO were not at higher risk of adverse health-related indicators; despite showing reduced physical function, they reported more physical activity, higher happiness, and less screen time compared to adolescents without disabilities during the COVID-19 pandemic.

ABSTRACT Soybean tolerance to defoliation may be affected by population density, as the plant population interferes with the crop leaf area index . This study aimed to evaluate the effect of defoliation at the beginning of pod formation on the agronomic performance of soybean at different plant densities. The experiment was conducted under field conditions in Campos Novos, SC, Brazil, during 2016/2017 and 2017/2018 growing season. The experimental design was a randomized block in a split-plot arrangement. The main plot consisted of three densities (100,000, 300,000, and 500,000 plants ha−1), whereas the subplots consisted of the cultivar NA 5909 RG submitted to five defoliation levels (0, 16.6, 33.3, 50, and 66.6%). Grain yield ranged from 4,219 to 5,356 kg ha−1 in the 2016/2017 growing season and 3,732 to 5,186 kg ha−1 in the 2017/2018 growing season. Plant density did not interfere with the grain yield response to defoliation performed at the beginning of pod formation. The 16.6% defoliation increase grain yield by 7.5 and 5.6% relative to the control in 2016/2017 and 2017/2018 growing seasons, respectively. The soybean tolerate defoliation of up to 33.3% at R3 with no significant decrease in grain yield, regardless of the plant density.

ABSTRACT. Water deficiency reduces leaf expansion and photosynthetic efficiency, potentially reducing the ability to withstand leaf area (LA) loss. This study aimed to evaluate the effects of water restriction on soybean tolerance to defoliation in the vegetative and reproductive periods of development. Two experiments were conducted in a greenhouse located in Lages, Santa Catarina State Brazil, during the 2017/2018 growing season. Cultivar NA 5909 RG was subjected to three WR levels (none, moderate, and severe) and five defoliation levels (0, 17, 33, 50, and 67%). Defoliation occurred at the V6 stage in the first experiment and R3 in the second. WR occurred for 7 days after defoliation. LA at R2 and R5 after defoliation at V6 and R3 decreased by 27.5 and 64.6%, respectively, regardless of WR. LA between V6 and R2 was not influenced by WR or defoliation. Moderate or severe WR reduced plant ability to recover LA between R3 and R5. Severe WR decreased grain production by 22.2% in the vegetative period and 21.2% per plant in the reproductive period compared to that of the control, regardless of defoliation. The highest defoliation level reduced grain production per plant by 24.7 and 24.3% relative to the control at stages V6 and R3, respectively, regardless of WR. WR imposed at the vegetative and reproductive stages did not increase defoliation sensitivity.

Resumo Objetivo: estimar a prevalência e sintetizar evidências sobre a relação entre fragilidade e delirium em idosos hospitalizados. Método: revisão sistemática com metanálise na qual foram selecionados estudos observacionais realizados com idosos sobre fragilidade, delirium e hospitalização, sem recortes temporais e de idioma. A busca foi realizada nas bases de dados MEDLINE, EMBASE, CINAHL, Scopus, Web of Science e CENTRAL durante o mês de agosto de 2021. Foram seguidos os preceitos estabelecidos pelo Joanna Briggs Institute (JBI) - Grupos de Síntese de Evidências.. O modelo de metanálise estimou risco relativo da prevalência de fragilidade e delirium. Utilizou-se método da variância inversa para proporções para estimar as prevalências e risco relativo para desfechos binários. Resultados: identificaram-se, inicialmente, 1.244 artigos, 26 incluídos na metanálise (n=13.502 participantes), sendo a prevalência de fragilidade 34% (IC 95% 0,26 a 0,42; I 2=99%; t 2= 0,7618, p=0) e delirium 21% (IC 95% 0,17 a 0,25; I 2=95%; t 2= 0,3454, p<0,01). O risco do idoso frágil hospitalizado desenvolver delirium foi de 66% (RR 1,66; IC 95% 1,23 a 2,22; I2=92%; t2=0,4154; p<0,01). Conclusão: prevalência de 34% de fragilidade e 21% de delirium em idosos hospitalizados, sendo a fragilidade um fator de risco independente para desenvolvimento de delirium, com um aumento de chance de 66% comparado aos não frágeis.

Abstract Objective: to estimate the prevalence and synthesize diverse evidence about the relationship between frailty and delirium in hospitalized older adults. Method: a systematic review with meta-analysis in which observational studies conducted with older adults about frailty, delirium and hospitalization, were selected without time of language restrictions. The search was conducted in the MEDLINE, EMBASE, CINAHL, Scopus, Web of Science and CENTRAL databases during August 2021. The precepts set forth by the Joanna Briggs Institute (JBI) - Evidence Synthesis Groups were followed. The meta-analysis model estimated the relative risk corresponding to the prevalence of frailty and delirium. The inverse variance method for proportions was used to estimate the prevalence values and relative risks for binary outcomes. Results: initially, 1,244 articles were identified, of which 26 were included in the meta-analysis (n=13,502 participants), with 34% prevalence of frailty (95% CI:0.26-0.42; I 2=99%; t 2=0.7618, p=0) and 21% for delirium (95% CI:0.17-0,25; I 2=95%; t 2=0.3454, p<0.01). The risk for hospitalized older adults to develop delirium was 66% (RR: 1.66; 95% CI:1.23-2.22; I2=92%; t2=0.4154; p<0.01). Conclusion: 34% prevalence of frailty and 21% of delirium in hospitalized older adults, with frailty being an independent risk factor for developing delirium, with an increased chance of 66% when compared to non-frail individuals.

Resumen Objetivo: estimar la prevalencia y sintetizar evidencias sobre la relación entre fragilidad y delirium en adultos mayores hospitalizados. Método: revisión sistemática con metanálisis en el que se seleccionaron estudios observacionales realizados con adultos mayores sobre fragilidad, delirium y hospitalización, sin recorte temporal ni de idioma. La búsqueda se realizó en las bases de datos MEDLINE, EMBASE, CINAHL, Scopus, Web of Science y CENTRAL en agosto de 2021. Se siguieron los preceptos del Instituto Joanna Briggs (Joanna Briggs Institute, JBI) - Evidence Synthesis Groups. El modelo de metanálisis estimó el riesgo relativo de la prevalencia de fragilidad y delirium. Se utilizó el método de la varianza inversa para proporciones para estimar la prevalencia y el riesgo relativo de los desenlaces binarios. Resultados: inicialmente se identificaron 1.244 artículos, se incluyen en el metanálisis 26 (n=13.502 participantes), la prevalencia de fragilidad fue del 34% (IC 95% 0,26 a 0,42; I 2=99%; t 2= 0,7618, p=0) y de delirium del 21% (IC 95% 0,17 a 0,25; I 2=95%; t 2= 0,3454, p<0,01). El riesgo de que el adulto mayor frágil hospitalizado desarrolle delirium fue del 66% (RR 1,66; IC 95% 1,23 a 2,22; I2=92%; t2=0,4154; p<0,01). Conclusión: los adultos mayores hospitalizados tienen una prevalencia de fragilidad del 34% y de delirium del 21%, la fragilidad es un factor de riesgo independiente para el desarrollo de delirium, cuando se compara a los frágiles con los no frágiles, la probabilidad de delirium de los primeros es de un 66% más.

Objetivo: Avaliar violência interpessoal não sexual contra crianças e adolescentes em um hospital universitário terciário. Métodos: Foi realizado um estudo transversal com 240 pacientes em situação de violência não sexual por 15 anos. A análise incluiu: dados demográficos, local de referência do hospital, tipo e autor da violência, encaminhamento legal, exames laboratoriais e de imagem, e desfechos graves. Resultados: Situações de violência não sexual foram diagnosticadas em 240 de 295.993 (0,1%) pacientes durante os 15 anos do período: 148/240 (61,7%) em crianças e 92/240 (38,3%) em adolescentes. Os tipos de violências mais frequentes foram negligência em 156/240 (65,0%), violência física 62/240 (25,8%), agressão psicológica/emocional 52/240 (21,7%), síndrome de Münchausen por procuração 4/240 (1,7%) e bullying/cyberbullying em 3/240 (1,3%). As condições crônicas pediátricas mais frequentes foram: doença renal crônica 24/123 (19,5%), vírus da imunodeficiência humana 14/123 (11,4%), prematuridade 9/123 (7,3%), paralisia cerebral 8/123 (6,5%) e asma 8/123 (6,5%). Comparações entre crianças e adolescentes em situação de violência não sexual revelaram que houve diferença significativa entre os locais de referência do hospital. A frequência de pacientes sob violência encaminhados de ambulatórios foi significantemente reduzida em crianças versus adolescentes (27,7 vs. 62%), enquanto encaminhamentos de pronto-socorro foram mais numerosos no primeiro grupo (57,4 vs. 25%, p<0,001). Os tipos de violências e condições pediátricas crônicas foram semelhantes nos dois grupos(p>0,05). Conclusões: Violência não sexual na nossa população pediátrica foi raramente diagnosticada em um hospital terciário, principalmente negligência, agressão física e psicológica/emocional. Aproximadamente dois terços dos diagnósticos de violência ocorreram em crianças, preferencialmente encaminhadas pelo departamento de emergência. Em contrapartida, cerca de um terço dos diagnósticos de violência ocorreu em adolescentes, encaminhados principalmente pelos ambulatórios.

Abstract Objective: The objective of this study was to assess interpersonal nonsexual violence against children and adolescents in a tertiary university hospital. Methods: A cross-sectional study was performed in 240 patients under nonsexual violence situation for 15 consecutive years. Data analyses included demographic data, hospital referral site, type and author of nonsexual violence, legal referral, laboratorial and imaging examinations, and outcomes. Results: Nonsexual violence situation was diagnosed in 240 (0.1%) of 295,993 patients for 15 years: 148 (61.7%) in children and 92 (38.3%) in adolescents. Out of 240, the most frequent types of violence were negligence in 156 (65.0%), physical 62 (25.8%), psychological/emotional aggression 52 (21.7%), Munchausen by proxy syndrome 4 (1.7%), and bullying/cyberbullying in 3 (1.3%). Out of 123, the most common pediatric chronic conditions were chronic kidney disease 24 (19.5%), human immunodeficiency virus 14 (11.4%), prematurity 9 (7.3%), cerebral palsy 8 (6.5%), and asthma 8 (6.5%). Further comparison between children versus adolescent under nonsexual violence situation revealed significant difference between the hospital referral sites. The frequency of patients under violence referred from outpatient clinics was significantly reduced in children versus adolescents (27.7 vs. 62%), whereas emergency department was higher in the former group (57.4 vs. 25.0%; p<0.001). All types of violence situations and pediatric chronic conditions were similar in both groups (p>0.05). Conclusions: Nonsexual violence against our pediatric population was rarely diagnosed in a tertiary hospital, mainly negligence, physical, and psychological/emotional aggression. Approximately two-thirds of violence diagnosis occurred in children, referred mainly by the emergency department. In contrast, approximately one-third of violence diagnosis occurred in adolescents, referred mostly by outpatient clinics.